Demographics of treated patients
| Placebo(n = 113) | Sildenafil(n = 104) | |
|---|---|---|
| *EDSS (Extended Disability Status Scale) scores available for 89 men (placebo) and 83 men (sildenafil); †used by >10% of patients. | ||
| Mean age (range), years | 47 (23−65) | 45 (26−73) |
| Mean duration of ED | 6.1 | 5.2 |
| (range), years | (0.9−29.0) | (0.7−23.1) |
| Mean duration of MS | 10.1 | 10.7 |
| (range), years | (1.1−40.3) | (1.5−46.4) |
| Mean EDSS score (range)* | 4.06 (1.5–6) | 3.97 (1–6) |
| Concomitant medications, %† | ||
| Analgesics | 16.8 | 21.2 |
| Antibacterials | 13.3 | 13.5 |
| Antidepressants | 21.2 | 17.3 |
| Antiepileptics | 11.5 | 15.4 |
| Antihypertensives | 20.4 | 12.5 |
| Corticosteroids | 8.8 | 21.2 |
| Drugs affecting immune | 26.5 | 28.8 |
| response | ||
| Muscle relaxants/antispastic | 27.4 | 29.8 |
| agents | ||
| Drugs for rheumatic diseases | 22.1 | 16.3 |
| Vitamins | 19.5 | 15.4 |